Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA

The Journal of Infectious Diseases
Venkata G MekaHoward S Gold

Abstract

Linezolid is an important therapeutic option for infections caused by resistant gram-positive bacteria. We report the characterization of sequential methicillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates that developed resistance in a patient treated with a prolonged course of linezolid. Analysis of this series of clinical MRSA isolates detected, in the resistant isolates, the presence of a T2500A mutation in the domain V region of the 23S rRNA gene. In addition, the loss of a single copy of the 23S rRNA gene was found in 2 of the resistant isolates. As a result of these 2 factors, the proportion of mutant : wild-type 23S rRNA genes increased in association with an increase in the minimum inhibitory concentration of linezolid. The most recent isolate of this series was recovered 7 months after the patient discontinued linezolid and demonstrated reversion to a susceptible phenotype associated with a loss of the T2500A mutation.

Citations

Sep 28, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J R LentinoV L Yu
Oct 31, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A SorlozanoT Boquete
Jul 28, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A MazzariolG Cornaglia
Jul 3, 2013·European Journal of Medicinal Chemistry·Cosimo G FortunaRosario Musumeci
Mar 2, 2005·International Journal of Antimicrobial Agents·Dilip Nathwani
Aug 3, 2007·International Journal of Antimicrobial Agents·A L CaseyT S J Elliott
Mar 9, 2010·Nature Reviews. Microbiology·Dan I Andersson, Diarmaid Hughes
Dec 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Chen DavidovichAda Yonath
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Venkata G Meka, Howard S Gold
Jun 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brian A PotoskiDavid L Paterson
May 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George Sakoulas, Robert C Moellering
May 12, 2009·The Journal of Antimicrobial Chemotherapy·Apostolos LiakopoulosEfi Petinaki
Sep 21, 2010·The Journal of Antimicrobial Chemotherapy·Dafne BongiornoStefania Stefani
May 6, 2011·The Journal of Antimicrobial Chemotherapy·Silvia Garazzino, Pier-Angelo Tovo
Oct 20, 2011·The Journal of Antimicrobial Chemotherapy·Robert C Moellering
Sep 6, 2012·The Journal of Antimicrobial Chemotherapy·Bing GuRomney M Humphries
May 30, 2006·The Pediatric Infectious Disease Journal·Susanne M RobertsAdrian M Zelazny
Jan 22, 2005·Current Opinion in Pediatrics·John S Bradley
Nov 26, 2009·Antimicrobial Agents and Chemotherapy·Agnes WongD Ashley Robinson
Oct 7, 2009·Antimicrobial Agents and Chemotherapy·Jeffrey B LockeKaren Joy Shaw
Jan 24, 2008·Antimicrobial Agents and Chemotherapy·Silke BesierThomas A Wichelhaus
Mar 5, 2008·Antimicrobial Agents and Chemotherapy·Laura LawrenceJoyce Sutcliffe
Feb 24, 2010·Antimicrobial Agents and Chemotherapy·Pia Schulz zur WieschSebastian Bonhoeffer
Mar 2, 2011·Antimicrobial Agents and Chemotherapy·Yurika Ikeda-DantsujiYoshihito Niki
Oct 26, 2011·Antimicrobial Agents and Chemotherapy·Jeffrey B LockeKaren Joy Shaw
Dec 7, 2011·Antimicrobial Agents and Chemotherapy·Katherine S Long, Birte Vester
May 27, 2005·Antimicrobial Agents and Chemotherapy·Jeffrey J CampionMartin E Evans
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·George SakoulasGeorge M Eliopoulos
Jul 6, 2012·Clinical Microbiology Reviews·Barbara A Brown-ElliottRichard J Wallace
Apr 15, 2006·Clinical Microbiology Reviews·Deirdre ChurchRobert Lindsay
Jul 20, 2007·Journal of Clinical Microbiology·Fred C TenoverJohn E McGowan
Dec 28, 2012·Journal of Clinical Microbiology·Inmaculada Quiles-MeleroJesús Mingorance

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.